Active Ingredient: ATOVAQUONE
Proprietary Name: ATOVAQUONE
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 750MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209685
Product Number: 001
Approval Date: Nov 21, 2018
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS SA
Marketing Status:
Prescription
Patent and Exclusivity Information